Ideal Criteria for Accurate Mouse Models of Vector-Borne Diseases with Emphasis on Scrub Typhus and Dengue.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 1 7 2020
medline: 11 11 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

Nine criteria regarding the infectious agent, mode of transmission, portal of entry, route of spread, target organs, target cells, pathologic lesions, incubation period, and modifiable spectrum of disease and outcomes appropriate to the intended experimental purpose are described. To provide context for each criterion, mouse models of two vector-borne zoonotic infectious diseases, scrub typhus and dengue, are summarized. Application of the criteria indicates that intravenous inoculation of

Identifiants

pubmed: 32602433
doi: 10.4269/ajtmh.19-0955
pmc: PMC7470543
pii: tpmd190955
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-975

Références

Annu Rev Immunol. 2011;29:587-619
pubmed: 21219187
Am J Pathol. 1945 Jul;21(4):603-81
pubmed: 19970829
Curr Opin Virol. 2017 Aug;25:76-80
pubmed: 28802204
J Gen Virol. 2015 Oct;96(10):3035-3048
pubmed: 26296350
ScientificWorldJournal. 2012;2012:525947
pubmed: 22666132
Microbes Infect. 2010 Jul;12(7):546-54
pubmed: 20381635
J Gen Virol. 2012 Oct;93(Pt 10):2152-2157
pubmed: 22815273
PLoS Negl Trop Dis. 2012 Jan;6(1):e1466
pubmed: 22253938
Ann Acad Med Singap. 2011 Dec;40(12):523-32
pubmed: 22294063
J Virol. 2012 Jul;86(14):7637-49
pubmed: 22573866
Am J Pathol. 2019 Jan;189(1):115-123
pubmed: 30315767
PLoS Negl Trop Dis. 2017 Jul 19;11(7):e0005763
pubmed: 28723951
Zentralbl Bakteriol Orig. 1955 Jun;163(2-3):149-53
pubmed: 13257655
Lab Invest. 1994 Mar;70(3):358-68
pubmed: 7511715
PLoS Pathog. 2012;8(10):e1002934
pubmed: 23055924
Vaccine. 2015 Dec 10;33(50):7051-60
pubmed: 26478201
J Virol. 2012 Dec;86(23):12561-70
pubmed: 22973027
PLoS One. 2015 May 04;10(5):e0125476
pubmed: 25938762
J Virol. 2014 Feb;88(4):2205-18
pubmed: 24335303
Sci Rep. 2018 Mar 20;8(1):4900
pubmed: 29559699
Front Immunol. 2014 Apr 10;5:151
pubmed: 24782859
PLoS Pathog. 2014 Apr 03;10(4):e1004031
pubmed: 24699622
Viruses. 2012 Jan;4(1):62-82
pubmed: 22355452
Proc Soc Exp Biol Med. 1946 Jun;62(2):138-40
pubmed: 20993147
PLoS Pathog. 2010 Feb 12;6(2):e1000790
pubmed: 20168989
J Virol. 2006 Oct;80(20):10208-17
pubmed: 17005698
PLoS Negl Trop Dis. 2016 Aug 01;10(8):e0004884
pubmed: 27479584
J Neurovirol. 2012 Oct;18(5):374-87
pubmed: 22825914
PLoS Pathog. 2011 Feb;7(2):e1001297
pubmed: 21379341
J Virol. 2005 Nov;79(21):13797-9
pubmed: 16227299
PLoS Negl Trop Dis. 2017 Mar 10;11(3):e0005453
pubmed: 28282373
Am J Trop Med Hyg. 2019 Feb;100(2):411-419
pubmed: 30652671
PLoS Pathog. 2014 Dec 04;10(12):e1004541
pubmed: 25474197
Front Cell Infect Microbiol. 2017 Oct 25;7:449
pubmed: 29119088
Immun Inflamm Dis. 2016 Aug 28;4(4):427-440
pubmed: 27980777
Cell Host Microbe. 2010 Nov 18;8(5):410-21
pubmed: 21075352
Adv Virus Res. 2003;60:421-67
pubmed: 14689700
PLoS Negl Trop Dis. 2012;6(5):e1663
pubmed: 22666512
PLoS Negl Trop Dis. 2010 Apr 27;4(4):e672
pubmed: 20436920
Am J Trop Med Hyg. 2009 Mar;80(3):416-24
pubmed: 19270292
PLoS Negl Trop Dis. 2014 Jul 10;8(7):e2966
pubmed: 25010338
Vaccine. 2011 Sep 23;29(42):7221-8
pubmed: 21781999
J Gen Virol. 2017 Oct;98(10):2507-2519
pubmed: 28949904
J Immunol. 1961 Jun;86:613-7
pubmed: 13786026
J Virol. 2012 Nov;86(22):12138-47
pubmed: 22933295
Antiviral Res. 2018 Jun;154:104-109
pubmed: 29665374
PLoS Pathog. 2016 Jun 16;12(6):e1005676
pubmed: 27310141
J Infect Dis. 2015 Sep 15;212(6):968-77
pubmed: 25737562
J Immunol. 1953 May;70(5):461-72
pubmed: 13052922
J Virol. 2015 Jan 15;89(2):1254-66
pubmed: 25392217
Lab Invest. 2000 Sep;80(9):1361-72
pubmed: 11005205
PLoS One. 2013;8(1):e54570
pubmed: 23342173
Antiviral Res. 2008 Nov;80(2):87-93
pubmed: 18619493
Mod Pathol. 2001 Aug;14(8):752-9
pubmed: 11504834
Hum Pathol. 2014 Jun;45(6):1221-33
pubmed: 24767772
PLoS One. 2011;6(6):e20762
pubmed: 21695193
Cell Host Microbe. 2010 Feb 18;7(2):128-39
pubmed: 20153282

Auteurs

Vanessa V Sarathy (VV)

1Department of Pathology, Sealy Institute for Vaccine Sciences, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas.

David H Walker (DH)

1Department of Pathology, Sealy Institute for Vaccine Sciences, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas.
2Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH